On March 22nd, Asieris Pharmaceuticals announced that the company’s CEO, Dr. Kevin Pan, has been invited to present at the 6th Annual Drug Repositioning, Repurposing and Rescue Conference. Asieris is a China-based, clinical-stage private biopharma dedicated to making a global impact to healthcare through developing innovative drugs for the treatment of cancers and multidrug resistant infections.
Drug Repositioning, Repurposing and Rescue Conference is the largest international meeting that highlights the latest advances in the fields of repositioning and repurposing of old drugs to expedite the development of innovative drugs. This year’s event will be held on June 27-28th, in Chicago, USA.
Dr. Kevin will use APL-1202 (currently in a pivotal trial in China) as examples to illustrate Asieris’ approaches to drug repositioning. The challenges and opportunities the company has encountered will also be discussed.
For more information for conference please visit: http://www.drugrepositioningconference.com
